BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 11582511)

  • 1. Measles virus interactions with cellular receptors: consequences for viral pathogenesis.
    Schneider-Schaulies J; ter Meulen V; Schneider-Schaulies S
    J Neurovirol; 2001 Oct; 7(5):391-9. PubMed ID: 11582511
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A matrix-less measles virus is infectious and elicits extensive cell fusion: consequences for propagation in the brain.
    Cathomen T; Mrkic B; Spehner D; Drillien R; Naef R; Pavlovic J; Aguzzi A; Billeter MA; Cattaneo R
    EMBO J; 1998 Jul; 17(14):3899-908. PubMed ID: 9670007
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Receptor use by vesicular stomatitis virus pseudotypes with glycoproteins of defective variants of measles virus isolated from brains of patients with subacute sclerosing panencephalitis.
    Shingai M; Ayata M; Ishida H; Matsunaga I; Katayama Y; Seya T; Tatsuo H; Yanagi Y; Ogura H
    J Gen Virol; 2003 Aug; 84(Pt 8):2133-2143. PubMed ID: 12867645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Receptor usage and differential downregulation of CD46 by measles virus wild-type and vaccine strains.
    Schneider-Schaulies J; Schnorr JJ; Brinckmann U; Dunster LM; Baczko K; Liebert UG; Schneider-Schaulies S; ter Meulen V
    Proc Natl Acad Sci U S A; 1995 Apr; 92(9):3943-7. PubMed ID: 7732009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Receptor (CD46)- and replication-mediated interleukin-6 induction by measles virus in human astrocytoma cells.
    Ghali M; Schneider-Schaulies J
    J Neurovirol; 1998 Oct; 4(5):521-30. PubMed ID: 9839649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD150 (SLAM) is a receptor for measles virus but is not involved in viral contact-mediated proliferation inhibition.
    Erlenhoefer C; Wurzer WJ; Löffler S; Schneider-Schaulies S; ter Meulen V; Schneider-Schaulies J
    J Virol; 2001 May; 75(10):4499-505. PubMed ID: 11312320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. One, two, or three step: measles virus receptor dance.
    Oldstone MB; Homann D; Lewicki H; Stevenson D
    Virology; 2002 Aug; 299(2):162-3. PubMed ID: 12202218
    [No Abstract]   [Full Text] [Related]  

  • 8. Measles infection of the central nervous system.
    Schneider-Schaulies J; Meulen Vt; Schneider-Schaulies S
    J Neurovirol; 2003 Apr; 9(2):247-52. PubMed ID: 12707855
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An immunohistochemical study of the distribution of the measles virus receptors, CD46 and SLAM, in normal human tissues and subacute sclerosing panencephalitis.
    McQuaid S; Cosby SL
    Lab Invest; 2002 Apr; 82(4):403-9. PubMed ID: 11950898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanism of CD150 (SLAM) down regulation from the host cell surface by measles virus hemagglutinin protein.
    Welstead GG; Hsu EC; Iorio C; Bolotin S; Richardson CD
    J Virol; 2004 Sep; 78(18):9666-74. PubMed ID: 15331699
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A CD46CD[55-46] chimeric receptor, eight short consensus repeats long, acts as an inhibitor of both CD46 (MCP)- and CD150 (SLAM)-mediated cell-cell fusion induced by CD46-using measles virus.
    Christiansen D; De Sousa ER; Loveland B; Kyriakou P; Lanteri M; Wild FT; Gerlier D
    J Gen Virol; 2002 May; 83(Pt 5):1147-1155. PubMed ID: 11961270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glycosyl-phosphatidylinositol-anchored and transmembrane forms of CD46 display similar measles virus receptor properties: virus binding, fusion, and replication; down-regulation by hemagglutinin; and virus uptake and endocytosis for antigen presentation by major histocompatibility complex class II molecules.
    Varior-Krishnan G; Trescol-Biémont MC; Naniche D; Rabourdin-Combe C; Gerlier D
    J Virol; 1994 Dec; 68(12):7891-9. PubMed ID: 7966579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Measles virus receptors: SLAM and CD46.
    Dhiman N; Jacobson RM; Poland GA
    Rev Med Virol; 2004; 14(4):217-29. PubMed ID: 15248250
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular and cellular aspects of measles virus persistence in the CNS.
    ter Meulen V
    J Neurovirol; 1997 May; 3 Suppl 1():S3-5. PubMed ID: 9179781
    [No Abstract]   [Full Text] [Related]  

  • 15. [The receptors and entry of measles virus: a review].
    Lu G; Gao GF; Yan J
    Sheng Wu Gong Cheng Xue Bao; 2013 Jan; 29(1):1-9. PubMed ID: 23631113
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Measles virus receptors.
    Yanagi Y; Takeda M; Ohno S; Hashiguchi T
    Curr Top Microbiol Immunol; 2009; 329():13-30. PubMed ID: 19198560
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Weak
    Shirogane Y; Hashiguchi T; Yanagi Y
    J Virol; 2020 Jan; 94(2):. PubMed ID: 31619560
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adaptation of wild-type measles virus to tissue culture.
    Kouomou DW; Wild TF
    J Virol; 2002 Feb; 76(3):1505-9. PubMed ID: 11773423
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human membrane cofactor protein (CD46) acts as a cellular receptor for measles virus.
    Naniche D; Varior-Krishnan G; Cervoni F; Wild TF; Rossi B; Rabourdin-Combe C; Gerlier D
    J Virol; 1993 Oct; 67(10):6025-32. PubMed ID: 8371352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extent of measles virus spread and immune suppression differentiates between wild-type and vaccine strains in the cotton rat model (Sigmodon hispidus).
    Pfeuffer J; Püschel K; Meulen Vt; Schneider-Schaulies J; Niewiesk S
    J Virol; 2003 Jan; 77(1):150-8. PubMed ID: 12477820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.